Articles tagged "Kidney transplantation"

2017 American Transplant Congress
Positive Flow Crossmatch After Negative Virtual Crossmatch -A Single Center Experience.
Q. Xu, S. Leckie.
Pathology and Lab Medicine, London Health Sciences Center, London, ON, Canada
Aims: To determine causes of Flow Cytometry crossmatch (FCXM) after a negative virtual crossmatch (VirXM), even with sensitive solid-phase antibody assay and complete HLA typings…
2017 American Transplant Congress
Awareness of Change in the Kidney Allocation System Among Dialysis Providers from Facilities with Low Waitlisting.
M. Basu,¹ K. Smith,¹ S. Pastan,¹ L. Plantinga,^1,2 S. Mohan,³ C. Escoffery,² J. Chung,¹ T. Melanson,² R. Patzer.^1,2
¹Emory University School of Medicine, Atlanta, GA; ²Rollins School of Public Health, Atlanta, GA; ³Columbia University, New York, NY
Background: In December 2014, the new kidney allocation system (KAS) was implemented and is expected to particularly benefit patients who have spent an extended time…
2017 American Transplant Congress
HLA Alloimmunization According to the Different Immunization Events and Consequences on Access to Kidney Transplantation.
V. Pernin,¹ A. Cros,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² V. Garrigue,¹ G. Mourad,¹ M. Le Quintrec-Donnette.¹
¹Department Nephrology and Transplantation, CHU Lapeyronie, Montpellier, France; ²Department of Immunology, CHU St ELoi, Montpellier, France
Patients awaiting solid organ transplantation may develop anti-HLA antibodies after sensitization events such as transfusions, pregnancies or previous transplantations. The aim of our work was…
2017 American Transplant Congress
Polypharmacy and Frailty in Kidney Transplant Recipients.
H. Ying, M. McAdams-DeMarco, D. Segev.
Department of Surgery, Johns Hopkins Medicine Institute, Baltimore, MD
Frailty is common in kidney transplant (KT) recipients with a prevalence of 20%, and is associated with post-KT adverse events including mortality, DGF, early hospital…
2017 American Transplant Congress
Is There a [bdquo]Weekend Effect“ in Kidney Transplantation? – A Single Center Study.
K. Schütte-Nütgen, G. Thölking, H. Pavenstädt, B. Suwelack, S. Reuter.
Department of Internal Medicine D, University Hospital Münster, Münster, Germany
The "weekend effect" describes increased adverse events and outcomes for patients hospitalized on weekends due to limited resources at hospitals and - in the context…
2017 American Transplant Congress
Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies.
A. Ralph,^1,2 P. Butow,¹ C. Hanson,^1,2 S. Chadban,^1,3 J. Chapman,¹ J. Craig,^1,2 J. Kanellis,⁴ G. Luxton,⁵ A. Tong.^1,2
¹University of Sydney, Sydney, Australia; ²Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia; ³Royal Prince Alfred Hospital, Sydney, Australia; ⁴Monash University, Melbourne, Australia; ⁵University of New South Wales, Sydney, Australia
Background: Many donors and recipients report an improved relationship after transplant, however tension, neglect, guilt and proprietorial concern over the recipient can impede donor and…
2017 American Transplant Congress
Donor-Derived Cell-Free DNA Parallels Increases in Donor Specific Antibodies in Pediatric Kidney Transplant Recipients.
D. Stoltz,¹ A. Brubaker,¹ M. Grskovic,² R. Woodward,² A. Gallo.¹
¹Surgery, Stanford University, Palo Alto, CA; ²CareDx, Brisbane, CA
Introduction: Anti-HLA antibody screening is a critical component of post-kidney transplant surveillance. Existing protocols and treatment plans are not standard/consistent across institutions. As increasing numbers…
2017 American Transplant Congress
Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients.
M. Levine,¹ K. Wen.²
¹Division of Urology, University of Alberta, Edmonton, AB, Canada; ²Department of Nephrology, University of Alberta, Edmonton, AB, Canada
INTRODUCITON AND OBJECTIVE: Kidney transplant longevity is largely related to immunosuppressive efficacy, which is highly dependent on patient adherence. Drug dosing frequency is one way…
2017 American Transplant Congress
A Novel Endpoint for Evaluating the Effect of Everolimus with Reduced Calcineurin Inhibitor on Long-Term Kidney Graft Outcome: The TRANSFORM Study Protocol.
T. Srinivas,¹ C. Legendre,¹ F. Oppenheimer,¹ H. Tedesco-Silva,¹ W.-L. Luo,² P. Bernhardt,² C. Sommerer,¹ S. Chadban,¹ F. Vincenti,¹ J. Pascual.¹
¹TRANSFORM Study Group, Murray; ²Novartis Pharma AG, Basel, Switzerland
Purpose: With the advancement of immunosuppressive (IS) agents, while short-term graft outcomes improved significantly, long-term outcomes remain a concern. Both acute rejection (AR) and nephrotoxicity…
2017 American Transplant Congress
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.
G. Malat, S. Guy, K. Ranganna, D. Reich, G. Xiao, S. Talluri, M. Harhay, L. Levin Mizrahi, C. Culkin.
Drexel University College of Medicine, Philadelphia
Hahnemann University Hospital has performed 113 kidney transplants, including 7 ReTx. Herein we describe characteristics and allograft outcomes of HIV(+) kidney transplant recipients based on…